Four Circle Pharmaceutical Holdings Group Co., Ltd. (“Four Circle Pharmaceuticals”) will hold its Annual General Meeting on 7 June 2024 at the Hilton Shenzhen Greater China Hotel in Shenzhen, China. The meeting will consider a number of resolutions including the adoption of the 2023 audited financial statements and the Directors' and Auditors' Reports. In addition, an election of directors will be held at the meeting, including the re-election of Dr. Che Feng Sheng, Mr. Tsang Huakwang and Dr. Chu Xun, and will authorize the Board of Directors to determine the remuneration of directors. EY Accounting Firm will be proposed to be renewed as auditor and authorized by the Board of Directors to determine their remuneration. The meeting will also discuss the granting...Show More

Four Circle Pharmaceutical Holdings Group Co., Ltd. (“Four Circle Pharmaceuticals”) will hold its Annual General Meeting on 7 June 2024 at the Hilton Shenzhen Greater China Hotel in Shenzhen, China. The meeting will consider a number of resolutions including the adoption of the 2023 audited financial statements and the Directors' and Auditors' Reports. In addition, an election of directors will be held at the meeting, including the re-election of Dr. Che Feng Sheng, Mr. Tsang Huakwang and Dr. Chu Xun, and will authorize the Board of Directors to determine the remuneration of directors. EY Accounting Firm will be proposed to be renewed as auditor and authorized by the Board of Directors to determine their remuneration. The meeting will also discuss the granting of general mandates to the directors to issue and repurchase shares, including the issuance of not more than 20% of the issued shares and the repurchase of not more than 10% of the shares. Shareholders may appoint representatives to attend the meeting and vote. The proxy form must be delivered to the designated location 48 hours prior to the meeting.